Nova Leap Health Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA66980G1090
CAD
0.31
-0.01 (-3.13%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
CareRx Corp.
WELL Health Technologies Corp.
dentalcorp Holdings Ltd.
CloudMD Software & Services, Inc.
Nova Leap Health Corp.
Numinus Wellness, Inc.
HealWELL AI, Inc.
BioMark Diagnostics, Inc.
Akumin, Inc.
Telo Genomics Corp.
Gemina Laboratories Ltd.

Why is Nova Leap Health Corp. ?

1
Poor long term growth as Operating profit has grown by an annual rate 24.99% of over the last 5 years
2
Negative results in Sep 25
  • NET PROFIT(HY) At CAD -0 MM has Grown at -100.72%
  • INTEREST(HY) At CAD 0.26 MM has Grown at 377.2%
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 24.00%, its profits have fallen by -105.1%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Nova Leap Health Corp. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Nova Leap Health Corp.
24.0%
-0.13
75.81%
S&P/TSX 60
21.87%
1.42
15.41%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
13.62%
EBIT Growth (5y)
24.99%
EBIT to Interest (avg)
-0.31
Debt to EBITDA (avg)
0.94
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
1.36
Tax Ratio
29.46%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.68%
ROE (avg)
2.19%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.07
EV to EBIT
18.94
EV to EBITDA
10.77
EV to Capital Employed
1.07
EV to Sales
0.66
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.64%
ROE (Latest)
-0.43%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

13What is working for the Company
PRE-TAX PROFIT(Q)

At CAD 0.87 MM has Grown at 341%

NET PROFIT(Q)

At CAD 0.63 MM has Grown at 367.27%

DEBTORS TURNOVER RATIO(HY)

Highest at 16.71 times

NET SALES(Q)

Highest at CAD 11.38 MM

RAW MATERIAL COST(Y)

Fallen by -3.08% (YoY

OPERATING PROFIT(Q)

Highest at CAD 0.9 MM

OPERATING PROFIT MARGIN(Q)

Highest at 7.89 %

-16What is not working for the Company
NET PROFIT(HY)

At CAD -0 MM has Grown at -100.72%

INTEREST(HY)

At CAD 0.26 MM has Grown at 377.2%

Here's what is working for Nova Leap Health Corp.

Pre-Tax Profit
At CAD 0.87 MM has Grown at 341%
over average net sales of the previous four periods of CAD 0.2 MM
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CAD MM)

Net Profit
At CAD 0.63 MM has Grown at 367.27%
over average net sales of the previous four periods of CAD 0.13 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (CAD MM)

Net Sales
Highest at CAD 11.38 MM and Grown
In each period in the last five periods
MOJO Watch
Near term sales trend is very positive

Net Sales (CAD MM)

Debtors Turnover Ratio
Highest at 16.71 times and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Operating Profit
Highest at CAD 0.9 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (CAD MM)

Operating Profit Margin
Highest at 7.89 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Raw Material Cost
Fallen by -3.08% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Nova Leap Health Corp.

Interest
At CAD 0.26 MM has Grown at 377.2%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CAD MM)